ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Direxion Daily Biotech Top 5 Bull 2X ETF
38.36
-0.5386
-1.38%
盤後:
38.53
0.1700
+0.44%
16:10 EDT
成交量:
7,280
成交額:
28.42萬
市值:
287.70萬
市盈率:
- -
高:
39.06
開:
39.06
低:
38.36
收:
38.90
52周最高:
45.88
52周最低:
25.71
股本:
7.50萬
流通股本:
7.50萬
量比:
0.49
換手率:
9.71%
股息:
0.62
股息率:
1.62%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
美國食品藥品監督管理局(FDA)批准吉利德治療艾滋病的每日一次複方片劑
路透中文
·
08/28
美國FDA批准吉利德科學Bixlenvo™上市:每日單片方案為病毒學抑制HIV成人患者提供新選擇,涵蓋複雜治療方案人群
美股速递
·
08/28
英國股市——8月27日需關注的因素
路透中文
·
08/27
阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標
路透中文
·
08/27
Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果,共同主要終點及所有關鍵次要終點全面達標
美股速递
·
08/27
美股開盤|三大指數升跌不一;Meta升逾3%、小鵬汽車升逾3%;生物科技股活躍
美股开盘
·
08/26
羅兵咸永道:上半年中國併購交易量7316宗創歷史新高 預計下半年延續強勁勢頭
智通财经
·
08/25
歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍,覆蓋所有PD-L1狀態
美股速递
·
08/24
吉利德科學:歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌
美股速递
·
08/24
美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。
智通财经
·
08/21
Piper Sandler上調安進目標價至457美元
格隆汇
·
08/21
美國研究綜述-安進、Analog Devices、莫德納
路透中文
·
08/20
港股早評:三大指數高開逾1.1%,生物科技股、黃金股大漲
中金财经
·
08/20
AI生物科技股Twist Bioscience升逾22%
格隆汇
·
08/20
福泰製藥(VRTX)股票8月19日收盤上漲4.48%:釋放什麼信號?
TradingKey中文
·
08/20
吉利德科學(GILD)股票8月19日盤中上漲3.66%:背後推手曝光
TradingKey中文
·
08/20
安進(AMGN)股票8月19日盤中上漲3.19%:背後推手曝光
TradingKey中文
·
08/20
再生元製藥旗下Pasatru獲歐洲藥品管理局審評,全球申報在即
美股速递
·
08/20
再生元製藥獲FDA批准:Pasatru(Garetosmab-Grts)上市,治療成人進行性骨化性纖維發育不良
美股速递
·
08/20
受利好消息提振,美股生物科技股普漲
智通财经
·
08/19
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/TBXU/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":38.3601,"timestamp":1789156800000,"preClose":38.8987,"halted":0,"volume":7280,"hourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"delay":0,"changeRate":-0.01384622108193835,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"未開盤","change":-0.5386,"latestTime":"09-11 16:00:00 EDT","open":39.06,"high":39.06,"low":38.3601,"amount":284204,"amplitude":0.017993,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":38.8987,"sharesOutstanding":100001,"nav":38.336,"aum":2875239.83,"dividendRate":0.01621,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"volumeRatio":0.4910292679310407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4910292679310407,"shares":75001,"dividePrice":0.6218,"high":39.06,"amplitude":0.017993,"preClose":38.8987,"low":38.3601,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":38.3601,"eps":0,"divideRate":0.01621,"volume":7280,"delay":0,"ttmEps":0,"open":39.06,"prevYearClose":31.065,"prevWeekClose":44.3833,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":45.76,"twentyDayClose":38.3309,"sixtyDayClose":29.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662036374","title":"美國食品藥品監督管理局(FDA)批准吉利德治療艾滋病的每日一次複方片劑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036374","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036374?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867453,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)批准吉利德治疗艾滋病的每日一次复方片剂路透8月27日-吉利德科学公司周四表示,美国食品和药物管理局已批准该公司研发的每日一次口服复方药GILD.O,用于治疗HIV病毒载量已降至极低水平的成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O24V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0861579265.USD","LU2112291526.USD","LU0889565916.HKD","LU2324357040.USD","IE00B7SZLL34.SGD","BK4532","BK4583","GILD","BK4568","IE00B3T34201.USD","SG9999015986.USD","BMED","BBH","LU0965509283.SGD","IBBQ","LU0289739699.SGD","TBXU","LU1061106388.HKD","BK4566","MEDI","IE0002270589.USD","LU1674673691.USD","LU1934455277.USD","SG9999015952.SGD","SG9999015945.SGD","LU0114720955.EUR","TMED","BIB","IBB","LU1037948541.HKD","LU0109394709.USD","LU1023059063.AUD","SG9999015978.USD","BK4139","LU1839511570.USD","IE00B19Z3581.USD","LU1066053197.SGD","IE00BKVL7J92.USD","LU0965508806.USD","LU1430594728.SGD","LU1778281490.HKD","BK4585","LU2468319806.SGD","LU1037948897.HKD","LU1934455194.USD","LU1571399168.USD","LU0965509101.SGD","LU0058720904.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198194055","title":"美國FDA批准吉利德科學Bixlenvo™上市:每日單片方案為病毒學抑制HIV成人患者提供新選擇,涵蓋複雜治療方案人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1198194055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198194055?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:49","pubTimestamp":1787867358,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了吉利德科学旗下新药Bixlenvo。这款每日一次的单片制剂,专为病毒学抑制状态的HIV成人感染者设计——即便是那些正在接受复杂治疗方案的病患,也适用这一新选项。此项获批标志着HIV治疗领域又添一枚重要砝码。Bixlenvo以单片复方形式呈现,将给药频率与用药负担同步压缩,患者无需再面对繁琐的多药组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU2357627491.SGD","SG9999015978.USD","LU1066051498.USD","LU1934455194.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU1674673428.USD","TMED","SG9999015952.SGD","IBB","LU1023059063.AUD","LU0320765992.SGD","BK4583","BK4588","LU2087621335.USD","BK4585","IBBQ","LU0965509010.AUD","LU1778281490.HKD","LU0965508806.USD","LU1585245621.USD","BK4578","BK4550","IE00B19Z3581.USD","LU0823416689.USD","LU0882574055.USD","LU2089984988.USD","TBXU","LU0289739699.SGD","LU0861579265.USD","LU0965509283.SGD","IE00B7SZLL34.SGD","LU1037948541.HKD","LU1571399168.USD","LU1674673691.USD","SG9999015986.USD","IE0002270589.USD","LU0109394709.USD","LU1430594728.SGD","BK4568","LU0889565916.HKD","LU1934455277.USD","BBH","BMED","LU2112291526.USD","BIB","LU0058720904.USD","LU0859254822.USD","LU1057294990.SGD","IE00B3T34201.USD","MEDI","LU2324357040.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0234570918.USD","LU0965509101.SGD","LU1037948897.HKD","IE00BSNM7G36.USD","LU1839511570.USD","LU2468319806.SGD","LU1066053197.SGD","LU1934455863.HKD","BK4532","GILD","SG9999015945.SGD","BK4139","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775484","title":"英國股市——8月27日需關注的因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775484","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:53","pubTimestamp":1787813617,"startTime":"0","endTime":"0","summary":"更新 1-英国股市——8月27日需关注的因素新增新闻报导,更新期货行情路透8月27日-预计周四英国富时100指数.FTSE将低开,期货FFIc1下跌0.4%。*7月汽车产量:行业数据显示,受出口疲软及部分工厂提前进行夏季检修停产影响,英国7月汽车产量 同比下降11.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU1880407132.USD","LU0171276677.USD","PPH.UK","LU0963555726.SGD","LU0969580561.USD","LU0553294199.USD","LU0171293334.USD","BK5105","LU0949170426.SGD","LU1057294990.SGD","LU0868494617.USD","BBH","LU0345780950.USD","LU1267930573.SGD","BK4139","LU1104425308.USD","BIB","GLEN.UK","PBE","BK4585","TBXU","SGXZ57979304.SGD","LU0857590862.USD","LU0889565916.HKD","LU0792757196.USD","PRU.UK","LU1989771016.USD","LU1355424745.HKD","IBB","LU0075056555.USD","LU2089984988.USD","PJP","IBBQ","LU1119994496.HKD","SG9999001176.SGD","LU0122379950.USD","LU1989772923.USD","LU1267930227.SGD","LU0310800379.SGD","AZN.UK","03165","LU2293690082.USD","CRDA.UK","LU0047713382.USD","GAW.UK","HFD.UK","LU0211326755.USD","IE0034235188.USD","LU0345777147.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639773","title":"阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639773","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:08","pubTimestamp":1787810905,"startTime":"0","endTime":"0","summary":"阿斯利康的哮喘药物Tezspire在食管炎晚期临床试验中达到了所有目标路透8月27日-阿斯利康(AstraZeneca)AZN.L周四表示,其与安进(Amgen)AMGN.O联合开发的哮喘药物Tezspire,在治疗嗜酸性粒细胞性食管炎(一种食管的慢性炎症性疾病)的晚期临床试验中达到了主要和次要研究目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923622614.USD","LU0949170426.SGD","LU0171276677.USD","BK5011","BIB","LU0011850046.USD","LU0203345920.USD","LU2237443549.SGD","LU1015430645.USD","LU0882574055.USD","LU1119994496.HKD","AMGN","LU2125909247.SGD","BK4139","LU2089284900.SGD","IBB","LU1273509221.SGD","LU1061106388.HKD","TBXU","PBE","AZN.UK","LU0432979614.USD","03165","LU1323610961.USD","LU2357627491.SGD","LU0889565916.HKD","IE00B2B36J28.USD","BBH","LU0211327993.USD","IE00BFTCPJ56.SGD","LU0211328371.USD","IBBQ","BK4588","BK4599","LU0757432116.USD","LU0390134368.USD","LU1267930813.SGD","LU1989772840.SGD","LU1196032939.SGD","PJP","LU1261432733.SGD","LU0158827948.USD","LU1064927863.SGD","LU1481599808.USD","LU0496365809.HKD","LU0960981461.USD","LU0640478417.SGD","LU0526926950.USD","LU0557290698.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146489142","title":"Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果,共同主要終點及所有關鍵次要終點全面達標","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489142","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146489142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810443,"startTime":"0","endTime":"0","summary":"Tezspire在针对嗜酸性食管炎的III期临床试验中取得了令人瞩目的积极结果。该试验不仅成功达到了共同主要终点,而且所有关键次要终点也悉数告捷。Tezspire的优异表现,标志着该领域治疗可能迎来重大变革。共同主要终点的同时达成,以及关键次要终点的全面覆盖,充分验证了Tezspire的疗效一致性和临床获益的广泛性。业内专家指出,Tezspire的这项研究成果,不仅巩固了其在炎症性疾病治疗领域的地位,更可能为后续的监管审批和市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","LU2242646821.SGD","IE0002141913.USD","LU1061106388.HKD","LU1057294990.SGD","BK4139","PJP","LU0868494617.USD","BBH","LU0889565916.HKD","SG9999001440.SGD","LU2089984988.USD","BK4585","IBB","LU0109394709.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1023059063.AUD","LU2112291526.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BIB","BK4581","IE00BJJMRZ35.SGD","BK4534","BK4566","LU0289739699.SGD","IBBQ","BK4533","BK4599","LU0058720904.USD","LU0122379950.USD","AMGN","LU2242652126.USD","TBXU","PBE","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106797728","title":"美股開盤|三大指數升跌不一;Meta升逾3%、小鵬汽車升逾3%;生物科技股活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=1106797728","media":"美股开盘","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106797728?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 21:30","pubTimestamp":1787751055,"startTime":"0","endTime":"0","summary":"投资者在英伟达财报公布前保持观望,市场情绪较为谨慎。公司拟通过部分赔偿及功能调整降低监管不确定性,股价盘前显著反弹。美国第二季度实际GDP年化季率维持1.5%。美国7月核心PCE同比增长3.3%,通胀黏性仍存。管理层警示激烈竞争对利润率造成压力,股价盘后回落近4%。营收及利润双双下滑,显示美国消费者支出放缓。公司宣称AI可服务的潜在市场规模高达30万亿美元,市场热议其估值合理性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK4505","BK4551","BK1610","BK4099","LU0593848301.USD","EVS.SI","BK1119","BK1588","XPEG","BK4526","TBXU","BK1587","BK4555","BK1539","XPEV","09868","BIOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662784028","title":"羅兵咸永道:上半年中國併購交易量7316宗創歷史新高 預計下半年延續強勁勢頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2662784028","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662784028?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 16:00","pubTimestamp":1787644859,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,普华永道指出,今年上半年,中国并购交易数量达7316宗,同比增加近30%,创下历史新高;交易总额同比增长56%至2416亿美元,为2023年以来最佳半年度表现。普华永道交易服务税务主管合伙人梅梁表示,预期中国并购市场在2026年下半年将延续强劲势头,全年交易总额有望实现同比增长。港交所仅上半年即录得51宗具私募股权背景的IPO,创下同期历史新高,超过半数为高科技企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MMID","UYG","PEVC","ACTV","GTPE","IBBQ","XLFI","BK4588","IEFN","PBPH","DFMC","IYH","TMED","PSP","TBXU","CANC","BK4585","AAUM","PRVT","RFG","VXF","FFSM","MNA","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍,覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定,将吉利德科学(Gilead Sciences)旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域,且不再受限于患者的PD-L1表达状态。这一举措意味着,无论生物标志物检测结果如何,符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择,也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应,认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1066053197.SGD","TMED","BK4566","LU2089984988.USD","LU2324357040.USD","BK4578","BBH","LU0122379950.USD","SG9999015952.SGD","TBXU","LU1057294990.SGD","BMED","BK4588","LU2468319806.SGD","BK4568","LU1934455863.HKD","LU0965509010.AUD","IBB","IE00B7SZLL34.SGD","LU1839511570.USD","BK4550","LU0320765992.SGD","IE00BSNM7G36.USD","BK4139","LU0114720955.EUR","LU0109394709.USD","LU0859254822.USD","LU1585245621.USD","LU1674673691.USD","LU2087621335.USD","LU2112291526.USD","IE00B19Z3581.USD","SG9999015978.USD","IE00BKVL7J92.USD","LU1037948541.HKD","LU0823416689.USD","LU0234570918.USD","LU0889565916.HKD","LU1934455277.USD","LU1934455194.USD","LU0882574055.USD","LU2357627491.SGD","BK4585","LU1061106388.HKD","LU1037948897.HKD","LU0861579265.USD","LU0965508806.USD","LU1571399168.USD","IBBQ","LU0058720904.USD","LU0965509101.SGD","LU0965509283.SGD","BIB","IE00B19Z3B42.SGD","BK4583","LU1674673428.USD","SG9999015986.USD","LU1430594728.SGD","BK4532","LU1023059063.AUD","LU1066051498.USD","LU1778281490.HKD","MEDI","GILD","LU0289739699.SGD","SG9999015945.SGD","IE00B3T34201.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學:歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布,欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步,为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357627491.SGD","IBBQ","LU0889565916.HKD","LU1066053197.SGD","SG9999015978.USD","LU0965509283.SGD","TBXU","IE00B7SZLL34.SGD","LU1037948897.HKD","GILD","IE0002270589.USD","LU0965509101.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","LU2324357040.USD","LU1674673691.USD","BMED","LU0861579265.USD","LU1934455277.USD","LU0965509010.AUD","BK4532","LU1778281490.HKD","LU0320765992.SGD","BK4566","BK4568","LU1430594728.SGD","BK4139","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0965508806.USD","LU1023059063.AUD","LU2087621335.USD","LU0882574055.USD","LU1585245621.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BBH","IBB","LU0058720904.USD","BK4583","LU1674673428.USD","LU1934455863.HKD","LU1037948541.HKD","LU1839511570.USD","LU2112291526.USD","SG9999015952.SGD","LU0109394709.USD","LU2089984988.USD","LU0859254822.USD","BK4578","MEDI","LU2468319806.SGD","LU1934455194.USD","IE00B3T34201.USD","BK4550","SG9999015986.USD","TMED","LU0122379950.USD","LU1571399168.USD","BK4585","LU1057294990.SGD","LU0823416689.USD","BK4588","LU0289739699.SGD","LU0234570918.USD","BIB","LU1061106388.HKD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBH","IXP","RSPT","HCA","JHMT","NBDS","KEMQ","TDAQ","TRUC","BUYO","DISC","PJP","PBE","TGRW","AMGN","IEME","NBCC","MSFY","GOOX","LRGG","QQMG","XLCI","ORCZ","IBB","MSFX","EMQQ","GXPC","WEBX","FCOM","ONEQ","FTC","WEBL","MNA","BIB","GXPT","CWC","EVNT","ARB","JHCS","MRGR","TBXU","GGTL","IHF","IBBQ","BWEB","DRUP","PBS","BCTK","MUSQ","PNQI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2468319806.SGD","LU0122379950.USD","IBB","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1057294990.SGD","UDN","BK4581","BK4534","IBBQ","IE00B4R5TH58.HKD","BK4566","BK4588","IE00B2B36J28.USD","BIB","LU1571399168.USD","LU0889565916.HKD","LU0320765992.SGD","PBE","LU1061106388.HKD","SG9999001440.SGD","AMGN","LU0058720904.USD","LU2112291526.USD","BK4585","IE0009355771.USD","LU2242652126.USD","LU0289739699.SGD","IE0002141913.USD","TBXU","BK4599","BBH","IE00BJT1NW94.SGD","LU0868494617.USD","LU1983299246.USD","LU2242646821.SGD","BK4533","LU2089984988.USD","PJP","UUP","IE00BJJMRZ35.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四,华尔街证券分析师上调了多家在美国上市公司的评级和目标股价,其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1119994496.HKD","LU0690374961.EUR","IE0009355771.USD","SG9999014542.SGD","WISE","LU2237443622.USD","LU0472753341.HKD","IE00B19Z9Z06.USD","LU2089985449.USD","CRWC","FXL","ARTY","LU1674673691.USD","LU1496350502.SGD","LU2491049909.HKD","LU1066053197.SGD","IE00BMPRXN33.USD","IE00B2B36J28.USD","LU2458330243.SGD","BK4185","MRNY","SNOU","LU2360107168.USD","MRVX","LU1670710661.SGD","LU0289739699.SGD","LU2506952097.USD","LU0795875086.SGD","LU0950375773.USD","LU2357627491.SGD","LU0094547139.USD","LU1023059063.AUD","LU2404859741.USD","LU2324357040.USD","LU2129689431.USD","LU1983299246.USD","LU2298321311.HKD","LU0889565833.HKD","VHT","BILL","IE00B5949003.HKD","LU0689626769.HKD","WCBR","LU1823568750.SGD","GLAM","LU2322448957.HKD","LU0056508442.USD","TJX","LU1670627923.USD","LU0823434740.USD","LU0312595415.SGD","04332","LU2237443549.SGD","IGV","SG9999000418.SGD","LU0823417737.USD","LU1267930490.SGD","TBXU","LU2468319806.SGD","SPAM","LU0689472784.USD","LU2087621335.USD","LU1923622614.USD","MRNA","LU1064131342.USD","LU0868494617.USD","LU2360106780.USD","LU1150488135.SGD","SNOY","LU2491050071.SGD","LU1934455863.HKD","BK4528","LU0128525689.USD","BK4533","LU2023250504.SGD","LU2322448791.USD","IE00B3S45H60.SGD","IE00BVYPNW00.USD","LU0302445910.USD","LU0320765646.SGD","LU1623119135.USD","LU2506951958.HKD","BK4585","MVLL","DAT","LU0265550946.USD","BK4551","IE00BLSP4239.USD","LU0912757837.SGD","LU0965509010.AUD","LU0943347566.SGD","FDTX","LU2098885051.SGD","GNOM","AGNG","LU0708994859.HKD","LU0980610538.SGD","LU0211327993.USD","LU1839511570.USD","LU0211328371.USD","LU0949170772.SGD","SG9999014013.SGD","LU0823417653.USD","CLOD","IE00BN8TJ469.HKD","SG9999014039.USD","LU0878866978.SGD","SG9999002232.USD","IE00BSNM7G36.USD","LU0444973449.USD","CLOU","LU1718418525.SGD","SG9999014021.USD","LU2125154778.USD","LU0320765992.SGD","LU0006306889.USD","LU0882574055.USD","LU0130102774.USD","LU0476273544.USD","LU2237443382.USD","LU2041044095.USD","LU0417517546.SGD","LU2272731865.HKD","IE00BD6J9T35.USD","IBB","LU0310799852.SGD","LU0274383776.USD","LU0823421333.USD","LU1861220033.SGD","LU0081259029.USD","LU0724618433.USD","LU0128525929.USD","RXL","LU1720051017.SGD","LU2237443978.SGD","LU1551013342.USD","LU1169590202.USD","LU2242646821.SGD","SG9999015341.SGD","SG9999015978.USD","BK4607","LU1116320901.HKD","LU2543165471.USD","LU0256863902.USD","LU1571399168.USD","LU2290526834.HKD","LU0256863811.USD","LU1670628061.USD","LU1674673428.USD","LU0456855351.SGD","LU0957808578.USD","LU1201861249.SGD","LU1642822529.SGD","BK4114","LU0823421416.USD","SG9999001176.SGD","LU1720051108.HKD","LU2089283258.USD","BK4504","LU0124676726.USD","IE000SO60NU8.SGD","LU1935042991.SGD","BK4535","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0069063385.USD","LU1267930573.SGD","LU0070302665.USD","IXJ","LU0211331839.USD","BK4554","HCA","LU1804176565.USD","LU0068578508.USD","LU0432979614.USD","LU2244417387.USD","LU2552382058.USD","LU2491050154.USD","IBBQ","LU2361045086.USD","LU2237443895.HKD","LU2433249047.HKD","LU2347655156.SGD","LU2355687059.USD","IE0004086264.USD","LU2133065610.SGD","LU2361044949.HKD","LU2552382132.HKD","LU0859254822.USD","IE0004091025.USD","SG9999014575.USD","LU0310800379.SGD","BK4599","LU1066051498.USD","LU1066051811.HKD","LU0965509101.SGD","TRUH","LU1061106388.HKD","LU1691799644.USD","IE0009356076.USD","LU2361044865.SGD","LU1732799900.SGD","LU1941712264.USD","LU1861214812.USD","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","SG9999015358.SGD","LU1551013425.SGD","HAKY","LU1992135472.HKD","WDNA","IE0004445239.USD","BK4155","BUG","LU0158827948.USD","LU1585245621.USD","LU0052756011.USD","BK4560","BK4559","LU2458330169.SGD","LU0058720904.USD","LU0154236417.USD","BK4516","LU2242652126.USD","LU1989771016.USD","IE00B19Z3B42.SGD","LU0444971666.USD","BK4596","BK4597","LU0210528500.USD","LU0077335932.USD","LU1712237335.SGD","LU0823411888.USD","LU0203345920.USD","LU1852331112.SGD","BK4141","LU2112291526.USD","LU2129689514.USD","SG9999011175.SGD","SOXY","LU1978683503.SGD","LU0985489474.SGD","LU1244550577.SGD","LU2125909916.SGD","LU0726765562.USD","LU0820561818.USD","BK4592","LU0648001328.SGD","LU0098860793.USD","LU1974910355.USD","LU2517655291.USD","IE00BKVL7J92.USD","BK4512","LU2404859667.USD","LU2506951875.HKD","LU1941712348.USD","LU1989764748.USD","FHLC","LU0942090050.USD","LU0314106906.USD","PPH","LU1923622291.USD","LU0965508806.USD","IE00B894F039.SGD","LU1548497426.USD","LU1815336760.USD","WUGI","LU0029864427.USD","LU0238689110.USD","LU0109392836.USD","MRVL","LU1489326972.SGD","LU1989763005.USD","MEDX","BK4130","LU0124384867.USD","BK4501","LU0661504455.SGD","LU1917777945.USD","LU0130517989.USD","BK4139","IE000WAW04H5.SGD","FTXL","LU1951200564.SGD","QQQA","LU0786609619.USD","LU0265550359.USD","LU0642271901.SGD","SGXZ57979304.SGD","IE00BZ9MQY76.HKD","IDNA","LU2250418816.HKD","DTCR","AIS","LU1929549753.HKD","LU0795875169.SGD","LU1035773651.USD","LU0861579265.USD","BK4568","LU2089284900.SGD","LU1267930227.SGD","BIB","IE0000B7K699.USD","IE00BJT1NW94.SGD","LU0553294199.USD","LU2360107325.USD","FAI","LU1951198990.SGD","LU1934455194.USD","SG9999015986.USD","LU0109394709.USD","LU2129689605.HKD","LU1093756168.USD","LU0820561909.HKD","BK4532","LU1235294995.USD","LU0187121727.USD","CRWD","LU1046421795.USD","WDAY","SG9999014559.SGD","LU1732800096.USD","XLV","LU1923623000.USD","BK4613","LU0106261372.USD","LU2347655073.USD","SG9999014567.USD","XNTK","LU1935043536.SGD","LU0395794307.EUR","SNOW","IE000M9KFDE8.USD","IE00B19Z9P08.USD","AIFD","IE00BBT3K403.USD","SG9999003800.SGD","IE00B1BXHZ80.USD","LU0289961442.SGD","LU1778281490.HKD","LU2461242641.AUD","BK4581","IE0002270589.USD","LU0289739343.SGD","LU2237443465.HKD","SG9999001176.USD","BK4094","IE0034235188.USD","PSWD","IE00B775SV38.USD","LU1989764664.SGD","SG9999015945.SGD","LU0965509283.SGD","LU1116320737.USD","LU2275660780.HKD","LU0823416689.USD","LU0097036916.USD","BK4515","BK4566","PBE","LU1066051225.USD","LU2125154935.USD","LOW","ABBV","LU2023250843.SGD","LU1303367103.USD","TGT","BK4548","LU1162221912.USD","MRK","LU1989772923.USD","IE00B19Z3581.USD","LU2272731600.USD","SG9999002224.SGD","LU2092937221.SGD","IE00B42XCP33.USD","IHE","SG9999001440.SGD","BK4561","LU1670711123.USD","EL","LU2552382215.SGD","IE00B5TLWC47.USD","LU0738911758.USD","LU1803068979.SGD","LU2298322129.HKD","LU2357305700.SGD","LU2264538146.SGD","BK4503","LU0320765489.SGD","LU1861215975.USD","LU0203347892.USD","IYH","LU1037948541.HKD","LU1037948897.HKD","LU2125909593.SGD","SG9999013999.USD","LU0477156953.USD","LU2360108059.USD","LU0127658192.USD","LU0985320562.USD","LU1291159041.SGD","BK4097","GTEK","ADI","LU2506952170.USD","LU0170899867.USD","IE000MB6IJN5.SGD","BBH","LU2211815571.USD","LU0234570918.USD","LU2106854487.HKD","AMGN","SMHX","IE00BVYPNV92.GBP","LU1496350171.SGD","XDAT","LU1169589451.USD","LU0053666078.USD","LU1506573853.SGD","LU1316542783.SGD","LU0266013472.USD","PAWZ","BK4588","LU0823434583.USD","SG9999014005.SGD","LU2272731782.SGD","LU1670710588.SGD","PJP","LU0082616367.USD","LU0690374615.EUR","LU2286300806.USD","LU1244550221.USD","LU1670711040.USD","LU0198837287.USD","LU1989772840.SGD","BK4007","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0208291251.USD","IE00B3PB1722.GBP","LU1261432733.SGD","LU1989773731.SGD","IE000F7OJYX1.SGD","LU2487616109.SGD","LU1992135399.USD","LU1150488218.USD","BK4550","LU0310800965.SGD","BK4116","AIPI","JDOC","BK4083","CIBR","BK4183","LU0061475181.USD","LU2931357623.SGD","IE00BGHQF631.EUR","SG9999015952.SGD","LU2517655028.SGD","LU0234572021.USD","LU1074936037.SGD","LU2089984988.USD","LU1430594728.SGD","BMED","LU1069347547.HKD","HRTS","BK4604","IE00BMPRXR70.SGD","LU1003077747.HKD","LU0122379950.USD","LU2265009873.SGD","LU0114720955.EUR","LU2125909247.SGD","IE00BMPRXQ63.HKD","LU1861219969.SGD","GDOC","LU1699723380.USD","IE00BLSP4452.SGD","IE00BDGV0183.EUR","LU0545039389.USD","LU2125909759.SGD","LU0433182093.SGD","BK4505","MRNX","PCTY","BK4543","BK4534","IE0002141913.USD","BK4023","BK4598","LGHT","CRWL","LU1988902786.USD","LU1934455277.USD","LU2517655374.HKD","BK4558","WOLF","LU0868494708.USD","LU2237438978.USD","LU2360032135.SGD","LU2023251221.USD","LU1084165304.USD","BK4605","IE00BZ199S13.USD","LU0057025933.USD","LU1244550494.USD","IHF","FTXH","LU2473716301.USD","MRVU","LU0719512351.SGD","IE000BZT7R73.USD","LU0314104364.USD","LU0511384066.AUD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660472972","title":"港股早評:三大指數高開逾1.1%,生物科技股、黃金股大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2660472972","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660472972?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:37","pubTimestamp":1787189821,"startTime":"0","endTime":"0","summary":"美股止住三连跌,日韩股市大幅反弹。港股三大指数集体高开,恒指涨1.11%,国指涨1.27%,恒生科技指数涨1.69%。大型科网股全线上涨,京东涨近3%,美团、阿里巴巴涨2%,腾讯、小米、百度皆上涨;mRNA肿瘤疫苗三期大获成功,全产业链迎来价值重估,生物医药股大涨,康希诺生物、云顶新耀大涨15%,金斯瑞生物科技大涨13%,金价大涨,黄金股领衔有色金属股上涨,另外,消费电子股、海运股、煤炭股部分走低。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260820/32340660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4588","VXUS","159562","GLDW","BIOY","TBXU","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660476170","title":"AI生物科技股Twist Bioscience升逾22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476170","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476170?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 06:26","pubTimestamp":1787178401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AGIX","CHAT","AIPO","VTHR","QTOC","ARTY","BIOY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰製藥(VRTX)股票8月19日收盤上漲4.48%:釋放什麼信號?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后,福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期,公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级,平均目标价达 563.25 美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU1035775433.USD","LU2324357040.USD","LU2468319806.SGD","VRTX","LU0432979614.USD","BBH","LU1778281490.HKD","IE00B19Z3B42.SGD","LU2237438978.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","IE0002270589.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU1585245621.USD","IDNA","IE0009355771.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","LU2456880835.USD","LU0417517546.SGD","LU2462157665.USD","IBB","LU1093756325.SGD","GNMX","LU0079474960.USD","LU0256863811.USD","PBE","BIB","LU2362541513.USD","BK4588","LU1674673428.USD","LU0823416689.USD","BK4532","LU2417539215.USD","LU0234570918.USD","BK4139","LU2362541273.HKD","IBBQ","LU0109394709.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU1674673691.USD","BK4567","LU2236285917.USD","LU0289739699.SGD","LU0320765992.SGD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660113478","title":"吉利德科學(GILD)股票8月19日盤中上漲3.66%:背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660113478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660113478?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 03:17","pubTimestamp":1787167048,"startTime":"0","endTime":"0","summary":"• 得益于HIV产品组合增长加速,吉利德上调了全年销售指引。\n• 联邦法院颁布禁令阻止海外进口,以保护其核心市场份额。\n• 分析师给予“买入”评级,平均目标价为157.79美元。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118864-market-movers-gild-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0965509101.SGD","BBH","BK4583","LU0058720904.USD","LU1057294990.SGD","LU1674673428.USD","LU2468319806.SGD","LU0289739699.SGD","BMED","LU0965508806.USD","LU2324357040.USD","LU0965509283.SGD","LU1934455194.USD","LU1839511570.USD","LU1934455863.HKD","SG9999015986.USD","LU1585245621.USD","BK4139","IE00BKVL7J92.USD","SG9999015952.SGD","LU1934455277.USD","TBXU","BK4532","LU0965509010.AUD","LU1778281490.HKD","TMED","BIB","BK4588","SG9999015978.USD","GILD","LU1023059063.AUD","IBBQ","LU0823416689.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","IBB","IE0002270589.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","BK4578","BK4550","MEDI","LU1037948541.HKD","SG9999015945.SGD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819420","title":"安進(AMGN)股票8月19日盤中上漲3.19%:背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819420","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:16","pubTimestamp":1787163383,"startTime":"0","endTime":"0","summary":"• Argus上调安进目标价,并重申“买入”评级。\n• 第二季度财务业绩超出华尔街的营收和盈利预期。\n• 技术指标显示 MACD 买入信号及 RSI 买入条件。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118749-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0122379950.USD","TBXU","PJP","SG9999001440.SGD","IBB","LU0289739699.SGD","IE00B2B36J28.USD","BK4585","BIB","BK4533","BK4534","LU0320765992.SGD","LU2242646821.SGD","BBH","AMGN","LU0058720904.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","PBE","LU1983299246.USD","BK4139","LU2468319806.SGD","LU1061106388.HKD","BK4566","IE00B4R5TH58.HKD","LU2242652126.USD","BK4581","IE0002141913.USD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0868494617.USD","IBBQ","LU1057294990.SGD","LU2112291526.USD","BK4599","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105025052","title":"再生元製藥旗下Pasatru獲歐洲藥品管理局審評,全球申報在即","url":"https://stock-news.laohu8.com/highlight/detail?id=1105025052","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105025052?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:00","pubTimestamp":1787162410,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布,其研发的药物Pasatru已被欧洲药品管理局纳入审评流程。与此同时,该公司正积极筹备在全球范围内提交该药物的上市申请。欧洲药品管理局的审评启动,为这款药物在欧洲地区的获批前景增添了重要砝码。业界分析认为,Pasatru若能顺利通过审评,有望为相关疾病领域带来新的治疗选择。再生元制药在创新药物研发领域深耕多年,此次针对Pasatru的全球布局,也彰显了其对这一候选药物商业潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","REGN","LU0058720904.USD","LU1974910355.USD","LU0823434583.USD","LU0882574055.USD","LU0823434740.USD","TBXU","LU0320765992.SGD","LU0289739699.SGD","LU0109394709.USD","LU2237438978.USD","LU0889565916.HKD","BK4139","LU0114720955.EUR","BK4585","LU1917777945.USD","LU2468319806.SGD","LU2362541273.HKD","LU2089984988.USD","LU2362540622.SGD","LU0823416689.USD","LU0053666078.USD","IBBQ","LU2362541513.USD","LU2023250504.SGD","BBH","LU2106854487.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188134905","title":"再生元製藥獲FDA批准:Pasatru(Garetosmab-Grts)上市,治療成人進行性骨化性纖維發育不良","url":"https://stock-news.laohu8.com/highlight/detail?id=1188134905","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188134905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 01:59","pubTimestamp":1787162353,"startTime":"0","endTime":"0","summary":"再生元制药公司今日宣布,其研发的新药Pasatru已获得美国食品药品监督管理局的正式批准,用于治疗成人进行性骨化性纤维发育不良。这一罕见疾病此前一直缺乏有效的治疗手段,此次获批为患者带来了新的希望。FDA的此次批准基于多项临床研究数据,结果显示Pasatru在减缓异位骨化进展方面表现出显著疗效,且安全性可控。未来,再生元制药计划进一步拓展Pasatru的适应症范围,并探索其在其他相关疾病中的潜在应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BBH","LU2468319806.SGD","LU0882574055.USD","LU2237438978.USD","LU2362541273.HKD","LU0058720904.USD","LU0823434740.USD","REGN","IBB","LU0320765992.SGD","LU0823416689.USD","LU0053666078.USD","LU0823434583.USD","LU1917777945.USD","LU0109394709.USD","LU0114720955.EUR","LU0889565916.HKD","LU2106854487.HKD","BK4585","LU2362541513.USD","LU0289739699.SGD","BK4139","IBBQ","LU2023250504.SGD","TBXU","LU2362540622.SGD","BK4588","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447273","title":"受利好消息提振,美股生物科技股普漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447273","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447273?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 19:21","pubTimestamp":1787138473,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BIOY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":151,"code":"91000000","status":"200"}]}}